STERIS’ (TSE:STE – Free Report) – Research analysts at Cormark decreased their FY2024 earnings per share estimates for shares of STERIS’ in a note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now forecasts that the company will post earnings per share of $0.77 for the year, down from their prior estimate of $0.90.
STERIS’ (TSE:STE – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The firm had revenue of C$231.38 million for the quarter, compared to analysts’ expectations of C$226.20 million.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- Golden Cross Stocks: Pattern, Examples and Charts
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Use Stock Screeners to Find Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- How to Choose Top Rated Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
